image
ADC Therapeutics SA ADCT
Healthcare - Biotechnology - NYSE - CH
Watchlist
$ 2.39
-9.81 %
$ 231 M
Market Cap
-1.0
P/E
CASH FLOW STATEMENT
-119 M OPERATING CASH FLOW
13.24%
Growth Rates
1Year 13.24%
3Years 11.07%
5Years 0.44%
7Years 0.00%
10Years 0.00%
-3.22 M INVESTING CASH FLOW
-28.23%
Growth Rates
1Year -28.23%
3Years -4.38%
5Years -5.12%
7Years 0.00%
10Years 0.00%
73.9 M FINANCING CASH FLOW
12557.84%
Growth Rates
1Year 12557.84%
3Years -46.96%
5Years 398.56%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis ADC Therapeutics SA
image
Net Income -240 M
Depreciation & Amortization 3.27 M
Capital Expenditures -3.22 M
Stock-Based Compensation 13.5 M
Change in Working Capital 44.3 M
Others 14.9 M
Free Cash Flow -122 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (240.1) (155.8) (230.0) (246.3) (116.5) (123.1) (89.9)
Depreciation & Amortization 3.3 2.3 2.6 2.2 1.6 0.7 0.3
Deferred Income Tax 37.1 (0.7) (21.5) 0.3 1.2 0.9 48 K
Stock Based Compensation 13.5 49.3 60.5 37.6 1.1 0.5 1.0
Other Operating Activities 23.2 1.1 (24.7) 25.1 (1.2) (0.9) 36 K
Change in Working Capital 44.3 (33.0) (20.3) 12.4 (7.9) 0.5 13.5
Cash From Operations (118.7) (136.8) (233.4) (168.7) (121.6) (121.4) (74.9)
INVESTING CASH FLOW
Capital Expenditures (3.2) (2.3) (6.4) (2.8) (2.1) (2.5) (3.2)
Other Items 0 (0.2) (0.3) 19 K 100 K 36 K 92 K
Cash From Investing Activities (3.2) (2.5) (6.7) (2.8) (2.2) (2.5) (3.2)
FINANCING CASH FLOW
Common Stock Repurchased 0 (0.2) 0 0 (0.1) 24 K 0
Total Debt Repaid 0 (2.7) 48.6 61.8 (1.0) 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 73.9 (4.3) 218.8 54 K 101.6 24 K 0
Cash From Financing Activities 73.9 (0.6) 267.4 495.0 100.5 24 K 197.2
CHANGE IN CASH
Net Change In Cash (47.8) (140.1) 27.3 323.6 (23.3) (123.9) 119.1
FREE CASH FLOW
Free Cash Flow (121.9) (139.1) (239.8) (171.5) (123.7) (123.8) (78.1)